Nuzenio

Neurothera Labs

Neurothera Labs news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 9 publisher sources 100/100 entity strength

Latest news

SciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center - TipRanksTipRanks · Thu, 06 Aug 2026 06:21:58 GMTNeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:05 GMTNeuroThera Labs Expands Tourette Drug Trial to Yale in Phase IIb Study - TipRanksTipRanks · Wed, 05 Aug 2026 18:36:37 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - finance.yahoo.comfinance.yahoo.com · Wed, 05 Aug 2026 12:48:44 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTQuantum clinical analytics milestone at SciSparc (Nasdaq: SPRC) - Stock TitanStock Titan · Fri, 31 Jul 2026 13:15:29 GMTSciSparc Announces NeuroThera Labs Achieves Milestone in Quantum-Enabled Clinical Trial Data Analytics Platform - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 12:30:00 GMT

Timeline

Thu, 06 Aug 2026 06:21:58 GMTSciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center - TipRanks
Thu, 06 Aug 2026 00:24:05 GMTNeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -
Wed, 05 Aug 2026 18:36:37 GMTNeuroThera Labs Expands Tourette Drug Trial to Yale in Phase IIb Study - TipRanks
Wed, 05 Aug 2026 13:00:51 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan
Wed, 05 Aug 2026 12:48:44 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - finance.yahoo.com
Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neurothera Labs.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.